– USA, CO – Transverse Medical, Inc., developer of the POINT-GUARD Cerebral Embolic Protection medical device, announced the appointment of David Blowers and Dr. Rahul Sharma (MD, MBBS, FRACP) to its Board of Directors.
About David C. Blowers
David Blowers is an experienced wealth management and finance professional, board director, and C-Suite Executive, and currently serves as Vice-Chairman of Northern Trust. In addition to his Board Role, Mr. Blowers will serve as the company’s Corporate Secretary. Mr. Blowers holds an MBA with a concentration in Finance from the Kellogg School of Northwestern University and completed his Bachelor of Arts degree in Government from Lawrence University.
About Dr. Rahul P. Sharma
Dr. Rahul Sharma is the Director of Structural Interventions at Stanford Healthcare, Associate Director of the Cardiac Catheterization Laboratory, and Clinical Associate Professor of Medicine at Stanford University. In addition to his clinical expertise in structural heart and cerebral embolic protection, he is a Co-Founder and Board Member of Synchron, Inc. the endovascular brain-computer interface company, and serves as CMO of Egnite, a company developing artificial intelligence for cardiovascular medicine.
Dr. Rahul Sharma said, “I’m looking forward to joining the Board and contributing my clinical expertise to the success of the next-generation POINT-GUARD and the company’s future clinical plans and strategy. The Point-Guard solution for Full Brain Protection is critically needed to address the risk of Stroke during TAVR and which fully meets the success criteria for cerebral embolic protection.”
About Transverse Medical, Inc.
Transverse Medical is an early-stage medical device company focused on the development of the POINT-GUARD Cerebral Embolic Protection medical device for use during Transcatheter Aortic Valve Replacements to protect patients from embolic debris (particles) that are dislodged and released (debris shower) into the cerebral blood flow that could lead to periprocedural stroke as a result of the TAVR procedure.
The next-generation Point-Guard is a breakthrough advancement for complete Cerebral Embolic Protection of the brain and is designed with operator ease of use and the ability to accommodate variable arch anatomies with low interference and full aortic arch stabilization.
For more information: https://www.transversemedical.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.